STOP Nitazenes Act
Sponsored By: Representative Latta, Robert E. [R-OH-5]
In Committee
Summary
Permanently classifies nitazene opioids as Schedule I controlled substances. This bill would define a broad chemical class called “2‑benzylbenzimidazole opioids,” list specific nitazene compounds, and set a timetable and process for the Attorney General to publish and implement rules.
Show full summary
- Law enforcement and courts would treat substances that meet the bill’s definition as Schedule I and subject them to Schedule I requirements. This includes named compounds such as isotonitazene and etonitazene.
- Researchers and clinicians would face clearer boundaries on which nitazene-type substances fall under Schedule I because the bill spells out structural features and specific named substances.
- The Attorney General would have to publish a list of covered substances and issue implementing rules within 1 year. The bill allows interim final rules to take effect immediately and requires a final rule under the Administrative Procedure Act.
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
2 provisions identified: 0 benefits, 1 costs, 1 mixed.
New Schedule I for nitazene opioids
If enacted, this bill would make any amount of a 2-benzylbenzimidazole opioid (called a nitazene) a Schedule I drug. That includes salts, isomers, and similar chemicals that act on the mu-opioid receptor. The bill names examples like etonitazene and isotonitazene. Any substance temporarily scheduled under 21 U.S.C. 811(h) and covered here would become permanently Schedule I on the date of enactment. The Attorney General would be allowed to publish a Federal Register list of substances that meet the definition. Manufacturers, distributors, possessors, and researchers would face Schedule I rules and penalties.
Faster rule timeline for Attorney General
If enacted, the bill would require the Attorney General to write rules to implement this Act within one year after enactment. The Attorney General would be allowed to issue those rules as interim final rules that take effect right away without showing good cause. Any interim final rule would have to give interested persons a chance to comment and to request a hearing. After those proceedings end, the Attorney General would have to issue a final rule in accordance with 5 U.S.C. 553.
Sponsors & CoSponsors
Sponsor
Latta, Robert E. [R-OH-5]
OH • R
Cosponsors
Rep. Vindman, Eugene Simon [D-VA-7]
VA • D
Sponsored 3/26/2026
Rep. Baumgartner, Michael [R-WA-5]
WA • R
Sponsored 3/27/2026
Rep. Joyce, David P. [R-OH-14]
OH • R
Sponsored 3/27/2026
Rep. Mann, Tracey [R-KS-1]
KS • R
Sponsored 4/9/2026
Rep. Pfluger, August [R-TX-11]
TX • R
Sponsored 4/27/2026
Rep. Baird, James R. [R-IN-4]
IN • R
Sponsored 4/27/2026
Rep. McDowell, Addison P. [R-NC-6]
NC • R
Sponsored 5/13/2026
Rep. Goldman, Craig A. [R-TX-12]
TX • R
Sponsored 6/30/2026
Rep. Moore, Tim [R-NC-14]
NC • R
Sponsored 7/13/2026
Rep. Calvert, Ken [R-CA-41]
CA • R
Sponsored 7/22/2026
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov